biotech.today

Details

  • ●Modalities: biologics manufacturing, cell engineering
  • ●Therapeutic areas: Undisclosed
  • ●Key targets:
  • ●Indications: Undisclosed
  • ●Funding: $220M

Partners & investors

  • Andreessen Horowitz· Investor
  • Canaan· Investor

Key considerations

  • ●AI tools in use: Kernel Platform
  • ●$220M Series B (2024)
  • ●Canaan, Andreessen Horowitz Bio + Health backing
Get live updates on Asimov’s hiring, filings, and partnerships. Follow in BT Pro →
Source: Company website, SEC / Companies House filings, press releases, Crunchbase · biotech.today analysis (Apr 2026)

Key people

Alec Nielsen

Co-Founder & CEO

synthetic-biologycell-engineering
Visit website →LinkedIn →